<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS AND BACKGROUND: The aims of the current study were to evaluate whether recepteur d'origine nantais (RON) affects <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell behavior and oncogenic signaling pathways in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and to examine the relationship of its expression with various clinicopathological parameters and patient survival </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Immunohistochemistry, Western blot and RT-PCR were used to detect the expression of the RON gene in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissue </plain></SENT>
<SENT sid="2" pm="."><plain>To study the biological role of RON in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell behavior and cellular signaling pathways, we used small interfering <z:chebi fb="40" ids="33697">RNA</z:chebi> (siRNA) to knock down RON gene expression in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Knockdown of RON inhibited the induction of the invasive growth phenotype and the activation of oncogenic signaling pathways including Akt, MAPK and Î²-catenin </plain></SENT>
<SENT sid="4" pm="."><plain>RON overexpression was associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, lymphovascular invasion, depth of invasion, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage and poor survival </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: These results suggest that RON overexpression may help in predicting poor clinical outcomes in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>